Multimodality treatment in immunocompromised patients with severe
COVID
‐19: the role of
IL
‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
2003 ◽
Vol 33
(8)
◽
pp. 341-344
◽
2016 ◽
Vol 27
(3)
◽
pp. 317-327
◽
Keyword(s):
2009 ◽
Vol 87
(2)
◽
pp. 227-232
◽
2015 ◽
Vol 41
(2)
◽
pp. 179-182
◽
2017 ◽
Vol 21
(1)
◽
pp. 64-69
◽